Gil Moravsky
Overview
Explore the profile of Gil Moravsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcus G, Monayer A, Low A, Maymon S, Orbach A, Kalmanovich E, et al.
ESC Heart Fail
. 2025 Mar;
PMID: 40038881
Aims: The study aims to investigate the impact of immigration status on short- and long-term outcomes in patients hospitalized with acute decompensated heart failure (ADHF). Methods: We conducted a retrospective...
2.
Stone G, Lindenfeld J, Rodes-Cabau J, Anker S, Zile M, Kar S, et al.
Circulation
. 2024 Sep;
150(24):1931-1943.
PMID: 39308371
Background: An interatrial shunt may provide an autoregulatory mechanism to decrease left atrial pressure and improve heart failure (HF) symptoms and prognosis. Methods: Patients with symptomatic HF with any left...
3.
Marcus G, Najjar M, Monayer A, Orbach A, Maymon S, Kalmanovich E, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2024 Jul;
22:200306.
PMID: 39055966
Background: Acute Decompensated Heart Failure (ADHF) is associated with frequent hospitalizations, posing a significant health and economic burden globally. Despite advancements in heart failure management, studies delineating temporal trends in...
4.
Monayer A, Minha S, Maymon S, Pereg D, Kalmanovich E, Moravsky G, et al.
Int J Cardiol Heart Vasc
. 2024 Jun;
53:101431.
PMID: 38826832
Background: Statin therapy is well-established for treating hyperlipidemia and ischemic heart disease (IHD), but its role in Acute Decompensated Heart Failure (ADHF) remains less clear. Despite varying clinical guidelines, the...
5.
Pfeiffer M, Boehmer J, Gorcsan J, Eguchi S, Orihara Y, Laufer Perl M, et al.
ESC Heart Fail
. 2024 May;
11(5):2499-2509.
PMID: 38773938
Aims: Interatrial shunts are under evaluation as a treatment for heart failure (HF); however, their in vivo flow performance has not been quantitatively studied. We aimed to investigate the fluid...
6.
Rodes-Cabau J, Lindenfeld J, Abraham W, Zile M, Kar S, Bayes-Genis A, et al.
Eur J Heart Fail
. 2024 Apr;
26(4):1078-1089.
PMID: 38561314
Aims: Heart failure (HF) outcomes remain poor despite optimal guideline-directed medical therapy (GDMT). We assessed safety, effectiveness, and transthoracic echocardiographic (TTE) outcomes during the 12 months after Ventura shunt implantation...
7.
Levi N, Moravsky G, Weitsman T, Amsalem I, Bar-Sheshet Itach S, Algur N, et al.
Eur J Heart Fail
. 2022 Sep;
25(2):313-318.
PMID: 36097844
Aims: To prospectively evaluate the incidence of myocardial injury after the administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19. Methods And Results: Health care workers who received...
8.
Alcalai R, Butnaru A, Moravsky G, Yagel O, Rashad R, Ibrahimli M, et al.
Eur Heart J Cardiovasc Pharmacother
. 2021 Jul;
8(7):660-667.
PMID: 34279598
Aims: Current guidelines recommend anticoagulation with a vitamin K antagonist to treat left ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral anticoagulants (DOACs) in...
9.
Maymon S, Moravsky G, Marcus G, Shuvy M, Pereg D, Epstein D, et al.
ESC Heart Fail
. 2020 Nov;
8(1):390-398.
PMID: 33232585
Aims: Efforts are constantly made to decrease the rates of readmission after acute decompensated heart failure (ADHF). ADHF admissions to internal medicine departments (IMD) were previously associated with higher risk...
10.
Weissler-Snir A, Hindieh W, Moravsky G, Ralph-Edwards A, Williams L, Rakowski H, et al.
Echocardiography
. 2019 Feb;
36(2):276-284.
PMID: 30729587
Background: Septal myectomy relieves left ventricular outflow obstruction (LVOTO) and is associated with excellent long-term outcomes. LVOTO is associated with diastolic dysfunction and increased left atrial (LA) size. We sought...